We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
10 Year Est. Return
AUM
$484M
AUM Growth
+$36.9M
Cap. Flow
+$6.09M
Cap. Flow %
1.26%
Top 10 Hldgs %
26.56%
Holding
273
New
13
Increased
78
Reduced
63
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 22.9%
2 Industrials 12.46%
3 Consumer Staples 12.36%
4 Energy 9.49%
5 Technology 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCRX
251
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
$211K 0.04%
+9,200
New +$195K
NTT
252
DELISTED
Nippon Telegraph & Telephone
NTT
$208K 0.04%
8,000
CNI icon
253
Canadian National Railway
CNI
$76.9B
$203K 0.04%
+4,000
New +$197K
TFC icon
254
Truist Financial
TFC
$63.3B
$202K 0.04%
5,982
BNY
255
Bank of New York Mellon
BNY
$106B
$201K 0.04%
+6,648
New +$204K
KWK
256
DELISTED
QUICKSILVER RESOURCES INC
KWK
$140K 0.03%
71,170
+10,800
+18% +$18.3K
ERIC icon
257
Ericsson
ERIC
$32.2B
$135K 0.03%
10,090
FRO icon
258
Frontline
FRO
$8.76B
$109K 0.02%
8,250
+80
+1% +$1K
ESEA icon
259
Euroseas
ESEA
$557M
$75K 0.02%
768
RVP icon
260
Retractable Technologies
RVP
$19.8M
$47K 0.01%
15,000
FNM
261
DELISTED
FANNIE MAE
FNM
$23K ﹤0.01%
17,700
TGIC
262
DELISTED
TRIAD GUARANTY INC
TGIC
$2K ﹤0.01%
16,000
CP icon
263
Canadian Pacific Kansas City
CP
$78.1B
-9,500
Closed -$231K
SRPT icon
264
Sarepta Therapeutics
SRPT
$1.57B
-7,150
Closed -$272K
NWSA
265
DELISTED
NEWS CORPORATION CL-A
NWSA
-10,000
Closed -$326K

Similar funds

Gerald L. Ray & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Gerald L. Ray & Associates held 273 positions worth $484M, up 8.3% from $447M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Gerald L. Ray & Associates's Q3 2013 filing shows 13 new, 78 increased, 63 reduced and 4 closed positions. Its largest new stake was Acadia Pharmaceuticals: 46,550 shares worth $1.28M. The largest sale was NEWS CORPORATION CL-A, an estimated $326K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q3 2013 buy was Acadia Pharmaceuticals: 46,550 shares worth $1.28M.
  • Gerald L. Ray & Associates added most to American International in Q3 2013, an estimated $430K increase.
  • Gerald L. Ray & Associates's biggest Q3 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $224K.
  • Gerald L. Ray & Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $326K.
  • Gerald L. Ray & Associates's ten largest holdings make up 27% of its $484M portfolio in Q3 2013.
  • Gerald L. Ray & Associates opened 13 new positions and closed 4 in Q3 2013.
  • Gerald L. Ray & Associates's portfolio value rose 8.3% quarter-over-quarter to $484M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2013, filed 5 Nov 2013.